Rhenovia Pharma

Press Releases Publications Newsletters

Stay connected & subscribe to Rhenovia News Feed

Get English News Feed

Home > News & Events > Press Releases

Press Releases

4 February 2013 - Press announcement: Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system

26 November 2012 - Press announcement: Rhenovia files two patent applications for RHEpatch™

31 May 2012 - Press Announcement: Rhenovia files patents for new treatment of Huntington's disease based on its Biosimulation Platform

30 March 2012 - Full Press Announcement: Rhenovia Pharma and Rhenovia Development Inc. announce the launch of new drug research programs for Huntington disease and Duchenne muscular dystrophies

5 February 2012 - Rhenovia Pharma opens first US office

Rhenovia’s RHETOX Project is selected by France’s Ministries of Defense and Economy, for a financing of €1.15 million

2 September 2011 - Rhenovia’s RHETOX Project is selected by France’s Ministries of Defense and Economy, for a financing of €1.15 million

26 April 2011 - Rhenovia signs an R&D contract with Sodiaal-Candia for studying the nutritional and therapeutic value of milk and its derivatives

Rhenovia Signs Two-Year EUR 500,000 Partnership with AFM to Support its Simulation Technology for Diseases of the Nervous System

11 December 2010 - Rhenovia Signs Two-Year EUR 500,000 Partnership with AFM to Support its Simulation Technology for Diseases of the Nervous System

13 November 2010 - Rhenovia offers Face-to-Face meetings at the 40th Meeting of the Society for Neuroscience, San Diego November 13-17, 2010

Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA

9 October 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA

25 September 2009 - 26 September 2009 - Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.

13 April 2009 - Biovalley news:Focus of the month

19 January 2009 - Rhenovia Pharma in Biotech Finances

29 July 2008 - Dernières Nouvelles d'Alsace / Conférence de Toulouse

15 July 2008 - L ' Usine Nouvelle Semaine du 10 au 16 juillet

Knowledge for growth European Strategies in the global economy

2 July 2008 - Knowledge for growth European Strategies in the global economy

24 April 2008 - The most promising Start-up / DNA Nr 97 du 24 avril 2008

RHENOVIA PHARMA AU PALMARES DES JEUNES ENTREPRISES INNOVANTES FRANCAISES LES PLUS PROMETTEUSES

8 April 2008 - RHENOVIA PHARMA AU PALMARES DES JEUNES ENTREPRISES INNOVANTES FRANCAISES LES PLUS PROMETTEUSES

20 March 2008 - Tribune Spectra Analyse

Journal des entreprises ( click on picture and on doc)

12 March 2008 - Journal des entreprises ( click on picture and on doc)

26 February 2008 - DNA - La recherche près du patient

Rhenovia Pharma, la pépite Alsacienne

20 February 2008 - Rhenovia Pharma, la pépite Alsacienne

La Tribune - Rhenovia Pharma modélise le système nerveux

8 November 2007 - La Tribune - Rhenovia Pharma modélise le système nerveux

Rhenovia Pharma signs its first contract with a big pharma company

1 October 2007 - Rhenovia Pharma signs its first contract with a big pharma company

Instantanés technique n°46

1 July 2007 - Instantanés technique n°46

News

News & Events

May 2013 - Rhenovia Pharma opens now its 2nd Round of Financing to individuals, companies and investment organizations

Apr 2013 - Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system

Press Releases

Feb 2013 - Press announcement: Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system

Nov 2012 - Press announcement: Rhenovia files two patent applications for RHEpatch™

Publications

Modeling & Simulation: CNS – Targeted Approach.

Model Behavior – Biosimulation offers a cost effective way of modeling complex data on rare and orphan diseases, offering hope for drug discovery and repositioning in the field.

Newsletters

Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform GEN News Highlights

Newsletter April 2008